| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Roope A Kallionpää, Sirkku Peltonen, Kim My Le, Eija Martikkala, Mira Jääskeläinen, Elnaz Fazeli, Pilvi Riihilä, Pekka Haapaniemi, Anne Rokka, Marko Salmi, Ilmo Leivo, Juha Peltone. Characterization of immune cell populations of cutaneous neurofibromas in neurofibromatosis 1. Laboratory investigation; a journal of technical methods and pathology. 2023-11-10. PMID:37949359. |
cutaneous neurofibromas (cnfs) are characteristic of neurofibromatosis 1 (nf1), yet their immune microenvironment is incompletely known. |
2023-11-10 |
2023-11-20 |
human |
| Sarah Attia, Mina Guirguis, Lu Q Le, Avneesh Chhabr. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment. Skeletal radiology. 2023-10-31. PMID:37903998. |
the aim of this study is to evaluate neurofibromatosis type 1 (nf1) patients with whole-body mri (wbmri) to investigate the frequency of plexiform neurofibromas (pnfs), diffuse neurofibromas (dnfs), and malignant peripheral nerve sheath tumors (mpnsts). |
2023-10-31 |
2023-11-08 |
Not clear |
| Constanza Del Puerto, Mauricio Aspee, Camila Downe. [Neurofibromas in Type I Neurofibromatosis. Description of a clinical case and literature review]. Andes pediatrica : revista Chilena de pediatria. vol 93. issue 5. 2023-10-31. PMID:37906895. |
neurofibromas are the most frequent cutaneous tumors in patients with nf1, showing multiple clinical manifestations. |
2023-10-31 |
2023-11-08 |
Not clear |
| Laura Fertitta, Christina Bergqvist, Kavita Sarin, Scott R Plotkin, Christopher Moertel, Andrea J Petersen, Ashley Cannon, Yemima Berman, Dominique C Pichard, Class Röhl, Andres Lessing, Bernadette Brizion, Bastien Peiffer, Philippe Ravaud, Viet-Thi Tran, Marie-Laure Armand, Sabine Moryousef, Salah Ferkal, Arnaud Jannic, Khaled Ezzedine, Pierre Wolkenstei. A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials. The British journal of dermatology. 2023-10-25. PMID:37877514. |
cutaneous neurofibromas (cnf) are considered one of the highest burdens of neurofibromatosis type 1 (nf1). |
2023-10-25 |
2023-11-08 |
Not clear |
| Kyle B Williams, Andrew R Marley, Justin Tibbitts, Christopher L Moertel, Kimberly J Johnson, Michael A Linden, David A Largaespada, Erin L Marcott. Perinatal folate levels do not influence tumor latency or multiplicity in a model of NF1 associated plexiform-like neurofibromas. BMC research notes. vol 16. issue 1. 2023-10-18. PMID:37848948. |
perinatal folate levels do not influence tumor latency or multiplicity in a model of nf1 associated plexiform-like neurofibromas. |
2023-10-18 |
2023-11-08 |
Not clear |
| Laurence Pacot, Audrey Sabbagh, Pierre Sohier, Djihad Hadjadj, Manuela Ye, Anne Boland-Auge, Delphine Bacq-Daian, Ingrid Laurendeau, Audrey Briand-Suleau, Jean-François Deleuze, Raphaël Margueron, Michel Vidaud, Salah Ferkal, Béatrice Parfait, Dominique Vidaud, Eric Pasmant, Pierre Wolkenstei. Identification of potential common genetic modifiers of neurofibromas: a genome wide association study in 1,333 neurofibromatosis type 1 patients. The British journal of dermatology. 2023-10-13. PMID:37831592. |
neurofibromatosis type 1 (nf1) is characterized by the highly variable and unpredictable development of benign peripheral nerve sheath tumors named cutaneous (cnfs), subcutaneous (scnfs), and plexiform (pnfs) neurofibromas. |
2023-10-13 |
2023-10-15 |
Not clear |
| Mihail Petrov, Teodora Sakelarova, Venelin Gergano. Other Nerve Sheath Tumors of Brain and Spinal Cord. Advances in experimental medicine and biology. vol 1405. 2023-07-16. PMID:37452945. |
multiple neurofibromas throughout the body are the hallmark of neurofibromatosis type 1 (nf1). |
2023-07-16 |
2023-08-14 |
Not clear |
| Verena Staedtke, Piotr Topilko, Lu Q Le, Kevin Grimes, David A Largaespada, Ross L Cagan, Matthew R Steensma, Anat Stemmer-Rachamimov, Jaishri O Blakeley, Steven D Rhodes, Ina Ly, Carlos G Romo, Sang Y Lee, Eduard Serr. Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas. The Journal of investigative dermatology. 2023-06-18. PMID:37330719. |
neurofibromatosis 1 (nf1) is caused by a nonfunctional copy of the nf1 tumor suppressor gene that predisposes patients to the development of cutaneous neurofibromas (cnfs), the skin tumor that is the hallmark of this condition. |
2023-06-18 |
2023-08-14 |
mouse |
| Yingjoy Li, Jaishri Blakeley, Ina Ly, Yemima Berman, Jonathan Lau, Pierre Wolkenstein, Christina Bergqvist, Wangcun Jia, Thomas E Milner, Nitesh Katta, Anthony J Durkin, Gordon T Kennedy, Rebecca Rowland, Carlos G Romo, Jane Fleming, Kristen M Kell. Current and Emerging Imaging Techniques for Neurofibromatosis Type 1-Associated Cutaneous Neurofibromas. The Journal of investigative dermatology. 2023-06-18. PMID:37330718. |
a consistent set of measurement techniques must be applied to reliably and reproducibly evaluate the efficacy of treatments for cutaneous neurofibromas (cnfs) in people with neurofibromatosis type 1 (nf1). |
2023-06-18 |
2023-08-14 |
Not clear |
| F Coulpier, P Pulh, L Oubrou, J Naudet, L Fertitta, J-M Gregoire, A Bocquet, A-M Schmitt, P Wolkenstein, K J Radomska, P Topilk. Topical delivery of MEK inhibitor binimetinib prevents the development of cutaneous neurofibromas in Neurofibromatosis type 1 mutant mice. Translational research : the journal of laboratory and clinical medicine. 2023-06-18. PMID:37331503. |
cutaneous neurofibromas (cnfs) are a hallmark of patients with the neurofibromatosis type 1 (nf1) genetic disorder. |
2023-06-18 |
2023-08-14 |
mouse |
| Chunhui Jiang, Renée M McKay, Sang Lee, Carlos Romo, Jaishri Blakeley, Muzlifah Haniffa, Eduard Serra, Matthew Steensma, David Largaespada, Lu Q L. Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1. The Journal of investigative dermatology. 2023-06-15. PMID:37318402. |
cutaneous neurofibromas (cnfs) are nf1-associated benign tumors that affect nearly 100% of patients with nf1. |
2023-06-15 |
2023-08-14 |
Not clear |
| Wei-Ning Wang, Hanako Koguchi-Yoshioka, Keisuke Nimura, Rei Watanabe, Atsushi Tanemura, Manabu Fujimoto, Mari Wataya-Kaned. Distinct transcriptional profiles in the different phenotypes of neurofibroma from the same neurofibromatosis 1 subject. The Journal of investigative dermatology. 2023-06-10. PMID:37301319. |
among the clinical phenotypes of nf1, cutaneous neurofibroma (cnf) and plexiform neurofibroma (pnf) have distinct clinical manifestations, and pnf should be closely monitored due to its malignant potential. |
2023-06-10 |
2023-08-14 |
human |
| Qianqian Gao, Siwei Qu, Ning Ma, Weixin Wang, Sen Chen, Zhe Yang, Yangqun L. Risk factors for intraoperative hemorrhage of Type I neurofibromatosis. BMC surgery. vol 23. issue 1. 2023-06-10. PMID:37301968. |
neurofibromatosis type i (nf1) is the most common type, and most cases are characterized by neurofibromas. |
2023-06-10 |
2023-08-14 |
Not clear |
| Qianqian Gao, Siwei Qu, Ning Ma, Weixin Wang, Sen Chen, Zhe Yang, Yangqun L. Risk factors for intraoperative hemorrhage of Type I neurofibromatosis. BMC surgery. vol 23. issue 1. 2023-06-10. PMID:37301968. |
neurofibromas in nf1 are mainly treated by surgery. |
2023-06-10 |
2023-08-14 |
Not clear |
| Sunetra Mondal, Neha Agrawal, Subhankar Chowdhur. Turner Syndrome and Neurofibromatosis 1: Rare Co-Existence with Important Clinical Implications. Journal of the ASEAN Federation of Endocrine Societies. vol 38. issue 1. 2023-05-30. PMID:37252421. |
she also had multiple café-au-lait macules and axillary freckles but no neurofibroma and did not fulfil the classic criteria for diagnosis of neurofibromatosis-1 (nf1). |
2023-05-30 |
2023-08-14 |
Not clear |
| Paola Bettinaglio, Eleonora Mangano, Viviana Tritto, Roberta Bordoni, Rosina Paterra, Arianna Borghi, Marinella Volontè, Cristina Battaglia, Veronica Saletti, Claudia Cesaretti, Federica Natacci, Mariarosa A B Melone, Marica Eoli, Paola Riv. New insights into the molecular basis of spinal neurofibromatosis type 1. European journal of human genetics : EJHG. 2023-05-22. PMID:37217626. |
spinal neurofibromatosis (snf) is a form of neurofibromatosis type 1 (nf1) characterized by bilateral neurofibromas involving all spinal roots. |
2023-05-22 |
2023-08-14 |
Not clear |
| Laura Fertitta, Kavita Y Sarin, Christina Bergqvist, Ekshika Patel, Bastien Peiffer, Sabine Moryousef, Marie-Laure Armand, Arnaud Jannic, Salah Ferkal, Philippe Ravaud, Viet-Thi Tran, Jaishri O Blakeley, Carlos G Romo, Khaled Ezzedine, Pierre Wolkenstei. cNF-Skindex in adults living with Neurofibromatosis 1: severity strata in France and validation in US adults. The Journal of investigative dermatology. 2023-05-06. PMID:37149083. |
cutaneous neurofibromas (cnf) contribute to the impairment of quality of life (qol) in individuals with neurofibromatosis 1 (nf1). |
2023-05-06 |
2023-08-14 |
Not clear |
| Chunhui Jiang, Ashwani Kumar, Ze Yu, Tracey Shipman, Yong Wang, Renee M McKay, Chao Xing, Lu Q L. Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. The Journal of clinical investigation. 2023-05-04. PMID:37140985. |
basement membrane proteins in extracellular matrix characterize nf1 neurofibroma development and response to mek inhibitor. |
2023-05-04 |
2023-08-14 |
Not clear |
| Min-Quan Yao, Yu-Peng Jiang, Bing-Hong Yi, Yong Yang, Da-Zhuang Sun, Jin-Xing Fa. Neurofibromatosis type 1 with multiple gastrointestinal stromal tumors: A case report. World journal of clinical cases. vol 11. issue 10. 2023-05-01. PMID:37122520. |
neurofibromatosis type 1 (nf1) is characterized by café-au-lait patches on the skin and the presence of neurofibromas. |
2023-05-01 |
2023-08-14 |
Not clear |
| Christy Behnam, Angel Juarez, Brian Watson, Mohamed Fari. Diffuse Neurofibroma in a Micronesian Male. Cureus. vol 15. issue 3. 2023-04-24. PMID:37090400. |
neurofibromatosis type 1 (nf1) is an autosomal dominant genetic disorder, with variable clinical features, most commonly including café-au-lait macules and neurofibromas. |
2023-04-24 |
2023-08-14 |
Not clear |